EDAP TMS SA

FOCL ·Healthcare, Medical Devices, France
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2026 FY2025 FY2024
Revenue $70.5M $69.4M
Cost of Revenue $40.5M $40.7M
Gross Profit $30.0M $28.7M
Gross Margin 42.5% 41.4%
Operating Expenses
Research & Development $9.7M $8.4M
SG&A Expense $17.7M $15.2M
Operating Income $-24.7M $-22.2M
Operating Margin -35.0% -32.0%
Interest Expense
Pretax Income $-28.8M $-20.3M
Income Tax Expense $438.0K $313.0K
Net Income $-29.2M $-20.6M
Net Margin -41.5% -29.7%
EPS (Basic) $-0.78 $-0.55
EPS (Diluted) $-0.78 $-0.55
Shares Outstanding (Basic) 37.5M 37.4M 37.3M
Shares Outstanding (Diluted) 37.5M 37.4M 37.3M
Dividends Per Share